Culture media is a key raw material in the biotechnology field. However, China lacks key research and development capabilities and production experience for culture media and has long relied on foreign imports. In stem cell medicine, the world lacks the technology to effectively produce mesenchymal stem cells in vitro. We use our self-developed high-efficiency serum-free culture medium to establish stem cell mass production process technology to fill the industry gap, and the cell production capacity is better than existing international production technology.
ITRI is a world-leading applied technology research institute with more than 6,000 outstanding employees. Its mission is to drive industrial development, create economic value, and enhance social well-being through technology R&D. Founded in 1973, it pioneered in IC development and started to nurture new tech ventures and deliver its R&D results to industries. ITRI has set up and incubated companies such as TSMC, UMC, Taiwan Mask Corp., Epistar Corp., Mirle Automation Corp., and Taiwan Biomaterial Co.
Name:
Phone:
Address:195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu, Taiwan 31040, R.O.C.
Platform for Oligonucleotide Drug Production (Nucleic Acid Drugs for the Treatment of Pulmonary Fibrosis)
Clinical Diagnosis And Image Prediction Assessment System For Brain Radiation Therapy (AVM - Arteriovenous Malformation)
Multiple Circulating Molecule Preparation and Detection Technology
Highly efficient hyaluronic acid conjugation technology and its applications in biopharmaceutical industry
Technology maturity:Trial production
Exhibiting purpose:Technology transactions、Patent transactions、Product promotion、Display of scientific results
Trading preferences:Exclusive license/assignment、Technical license/cooperation、New products development
Coming soon!